NSCLC STAGE IV
Clinical trials for NSCLC STAGE IV explained in plain language.
Never miss a new study
Get alerted when new NSCLC STAGE IV trials appear
Sign up with your email to follow new studies for NSCLC STAGE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood test guides precision strikes against lingering lung cancer
Disease control CompletedThis study tested a new strategy for controlling advanced lung cancer that has spread. It aimed to see if using a sensitive blood test to detect tiny amounts of leftover cancer could guide doctors to use targeted radiation or surgery on the remaining tumors. The goal was to see i…
Matched conditions: NSCLC STAGE IV
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New drug duo tested to fight Tough-to-Treat lung cancer
Disease control CompletedThis study tested whether adding a new drug called bemcentinib (BGB324) to an existing immunotherapy (pembrolizumab) could help control advanced lung cancer that had worsened after prior treatment. It involved 99 adults with a specific type of lung cancer (adenocarcinoma) whose d…
Matched conditions: NSCLC STAGE IV
Phase: PHASE2 • Sponsor: BerGenBio ASA • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New scan could tell doctors if cancer drugs will work
Diagnosis CompletedThis study tested whether a special PET scan could predict which patients with advanced lung cancer would respond well to immunotherapy drugs like nivolumab. Researchers scanned 80 patients before they started treatment to see if the scan results could forecast how long they woul…
Matched conditions: NSCLC STAGE IV
Phase: NA • Sponsor: The Netherlands Cancer Institute • Aim: Diagnosis
Last updated Apr 03, 2026 14:41 UTC